|   Press Release

Atlas Venture Announces $350 Million Fund XI

Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, today announced the closing of its eleventh fund, raising $350 million in a highly oversubscribed fundraise. With Fund XI, Atlas Venture will continue to advance its mission of doing well by doing good, building biotech companies to deliver high-impact therapies to patients.

Read more.